Search PubMed⌕ Search

PubMed · 11836210

Tumor classification by partial least squares using microarray gene expression data.

Abstract

MOTIVATION: One important application of gene expression microarray data is classification of samples into categories, such as the type of tumor. The use of microarrays allows simultaneous monitoring of thousands of genes expressions per sample. This ability to measure gene expression en masse has resulted in data with the number of variables p(genes) far exceeding the number of samples N. Standard statistical methodologies in classification and prediction do not work well or even at all when N < p. Modification of existing statistical methodologies or development of new methodologies is needed for the analysis of microarray data. RESULTS: We propose a novel analysis procedure for classifying (predicting) human tumor samples based on microarray gene expressions. This procedure involves dimension reduction using Partial Least Squares (PLS) and classification using Logistic Discrimination (LD) and Quadratic Discriminant Analysis (QDA). We compare PLS to the well known dimension reduction method of Principal Components Analysis (PCA). Under many circumstances PLS proves superior; we illustrate a condition when PCA particularly fails to predict well relative to PLS. The proposed methods were applied to five different microarray data sets involving various human tumor samples: (1) normal versus ovarian tumor; (2) Acute Myeloid Leukemia (AML) versus Acute Lymphoblastic Leukemia (ALL); (3) Diffuse Large B-cell Lymphoma (DLBCLL) versus B-cell Chronic Lymphocytic Leukemia (BCLL); (4) normal versus colon tumor; and (5) Non-Small-Cell-Lung-Carcinoma (NSCLC) versus renal samples. Stability of classification results and methods were further assessed by re-randomization studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Danh V Nguyen, David M Rocke. 2002. Tumor classification by partial least squares using microarray gene expression data.. https://doi.org/10.1093/bioinformatics%2F18.1.39

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Regression grading of colorectal carcinoma after preoperative radiochemotherapy. An inventory].

The treatment of patients with colorectal cancer has changed over the last decades. More and more patients receive combined modality treatments including (preoperative) radiotherapy and chemotherapy. To assess the colorectal cancer specimen after neoadjuvant therapy, the pathologist has to be familiar with the histological features induced by radiochemotherapy. Performing a standardized pathological procedure, different grades of tumour regression can be observed and tumour staging should be standardized using valid and reproducible criteria. These criteria are recommended in the forthcoming TNM classification (6th edition, 2002). In the review, these classification rules will be discussed for rectal cancer.

Colonic Neoplasms↗